BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25065288)

  • 1. Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin.
    Isakov E; Weisman-Shomer P; Benhar M
    Biochim Biophys Acta; 2014 Oct; 1840(10):3153-61. PubMed ID: 25065288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
    Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
    Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
    Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
    J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms that lead to the regulation of NLRP3 inflammasome expression and activation in human dental pulp fibroblasts.
    Zhang A; Wang P; Ma X; Yin X; Li J; Wang H; Jiang W; Jia Q; Ni L
    Mol Immunol; 2015 Aug; 66(2):253-62. PubMed ID: 25863775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1β production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages.
    Gicquel T; Robert S; Loyer P; Victoni T; Bodin A; Ribault C; Gleonnec F; Couillin I; Boichot E; Lagente V
    FASEB J; 2015 Oct; 29(10):4162-73. PubMed ID: 26116704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease.
    Liang L; Tan X; Zhou Q; Zhu Y; Tian Y; Yu H; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):402-14. PubMed ID: 23211828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide/adenosine triphosphate induces IL‑1β and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells.
    Xie Q; Shen WW; Zhong J; Huang C; Zhang L; Li J
    Int J Mol Med; 2014 Jul; 34(1):341-9. PubMed ID: 24789624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium-independent antioxidant and anti-inflammatory effects of thioredoxin reductase inhibition in alveolar macrophages.
    Staples S; Wall SB; Li R; Tipple TE
    Life Sci; 2020 Oct; 259():118285. PubMed ID: 32798556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients.
    Zheng Q; Ren Y; Reinach PS; Xiao B; Lu H; Zhu Y; Qu J; Chen W
    Exp Eye Res; 2015 May; 134():133-40. PubMed ID: 25701684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procyanidin B2 inhibits inflammasome-mediated IL-1β production in lipopolysaccharide-stimulated macrophages.
    Martinez-Micaelo N; González-Abuín N; Pinent M; Ardévol A; Blay M
    Mol Nutr Food Res; 2015 Feb; 59(2):262-9. PubMed ID: 25379992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyhydroxylated metallofullerenols stimulate IL-1β secretion of macrophage through TLRs/MyD88/NF-κB pathway and NLRP₃ inflammasome activation.
    Chen Z; Liu Y; Sun B; Li H; Dong J; Zhang L; Wang L; Wang P; Zhao Y; Chen C
    Small; 2014 Jun; 10(12):2362-72. PubMed ID: 24619705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NZ suppresses TLR4/NF-κB signalings and NLRP3 inflammasome activation in LPS-induced RAW264.7 macrophages.
    Xiang P; Chen T; Mou Y; Wu H; Xie P; Lu G; Gong X; Hu Q; Zhang Y; Ji H
    Inflamm Res; 2015 Oct; 64(10):799-808. PubMed ID: 26298161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species.
    Oh JY; Ko JH; Lee HJ; Yu JM; Choi H; Kim MK; Wee WR; Prockop DJ
    Stem Cells; 2014 Jun; 32(6):1553-63. PubMed ID: 24307525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronegative LDL induces priming and inflammasome activation leading to IL-1β release in human monocytes and macrophages.
    Estruch M; Rajamäki K; Sanchez-Quesada JL; Kovanen PT; Öörni K; Benitez S; Ordoñez-Llanos J
    Biochim Biophys Acta; 2015 Nov; 1851(11):1442-9. PubMed ID: 26327597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1β production.
    Hua KF; Chou JC; Ka SM; Tasi YL; Chen A; Wu SH; Chiu HW; Wong WT; Wang YF; Tsai CL; Ho CL; Lin CH
    J Cell Physiol; 2015 Apr; 230(4):863-74. PubMed ID: 25294243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alarmin HNP-1 promotes pyroptosis and IL-1β release through different roles of NLRP3 inflammasome via P2X7 in LPS-primed macrophages.
    Chen Q; Jin Y; Zhang K; Li H; Chen W; Meng G; Fang X
    Innate Immun; 2014 Apr; 20(3):290-300. PubMed ID: 23792296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble uric acid increases NALP3 inflammasome and interleukin-1β expression in human primary renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway.
    Xiao J; Zhang XL; Fu C; Han R; Chen W; Lu Y; Ye Z
    Int J Mol Med; 2015 May; 35(5):1347-54. PubMed ID: 25813103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ASM/Cer/TXNIP signaling module in the NLRP3 inflammasome activation.
    Jiang J; Shi Y; Cao J; Lu Y; Sun G; Yang J
    Lipids Health Dis; 2021 Feb; 20(1):19. PubMed ID: 33612104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylsulfonylmethane inhibits NLRP3 inflammasome activation.
    Ahn H; Kim J; Lee MJ; Kim YJ; Cho YW; Lee GS
    Cytokine; 2015 Feb; 71(2):223-31. PubMed ID: 25461402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichothecene mycotoxins activate NLRP3 inflammasome through a P2X7 receptor and Src tyrosine kinase dependent pathway.
    Kankkunen P; Välimäki E; Rintahaka J; Palomäki J; Nyman T; Alenius H; Wolff H; Matikainen S
    Hum Immunol; 2014 Feb; 75(2):134-40. PubMed ID: 24269698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.